The production of chemical and pharmaceutical products in Switzerland is on a steady upward trajectory from 2024 to 2028. The forecasted values indicate a gradual increase year-on-year: 2024 at 148.12 billion CHF, 2025 at 151.42 billion CHF, 2026 at 154.65 billion CHF, 2027 at 157.81 billion CHF, and 2028 at 160.91 billion CHF. Assuming the production was significantly lower in 2023, the consistent growth demonstrates strong industry health and expansion.
The year-on-year percentage increases are as follows:
- From 2024 to 2025: 2.23%
- From 2025 to 2026: 2.14%
- From 2026 to 2027: 2.04%
- From 2027 to 2028: 1.96%
The compound annual growth rate (CAGR) over these five years (2024-2028) averages out to approximately 2.09% per year.
Future trends to watch for include advancements in biotechnology, generational shifts in demand tied to demographic changes, and regulatory evolutions within the EU that could impact production costs and supply chains. Furthermore, tracking innovation developments and global competition will be critical in assessing long-term growth and sustainability in Switzerland's chemical and pharmaceutical sectors.
